Abstract: Fabrication method of a semiconductor device is provided. The method includes forming an etch layer on the substrate, forming a first transitional layer and a first barrier layer on the etch layer, forming first islands on the first transitional layer by patterning the first barrier layer, forming first trenches in the first transitional layer to expose the etch layer, transferring the pattern of the first trenches into the etch layer and removing the first island, forming a second transitional layer and a second barrier layer on the etch layer and the first trenches, forming second islands on the second transitional layer by patterning the second barrier layer, forming second trenches in the second transitional layer to expose the etch layer, and transferring the pattern of the second trenches into the etch layer.

Abstract: Semiconductor device is provided. The semiconductor device includes a base substrate and a first dielectric layer on the base substrate. The first dielectric layer contains a first trench and a second trench passing therethrough, and a width of the second trench is larger than a width of the first trench. The semiconductor device further includes a first gate dielectric layer and a first gate electrode in the first trench. A first recess is on the first gate dielectric layer between the first gate electrode and the first dielectric layer. The semiconductor device further includes a second gate dielectric layer and a second gate electrode in the second trench. A second recess is on the second gate dielectric layer between the second gate electrode and the first dielectric layer. The semiconductor device further includes a first protection layer in the first recess and a second protection layer in the second recess.

Abstract: Semiconductor device and fabrication method are provided.

Abstract: The present disclosure provides human fecal microbiota compositions, including fresh, frozen, and lyophilized compositions, for the treatment of disorders associated with dysfunctional microbiota, such as recurrent Clostridium difficile infection. In particular, the fecal microbiota composition comprises a cryoprotectant sugar, such as mannitol.

Abstract: The present invention provides new methods and kits for treating and preventing bacterial infection.

Abstract: A method and apparatus for video live streaming process are provided. The method may include obtaining a feature image preset for a service process, the feature image being an image block that identifies the service process, obtaining a video screenshot from a video live streaming data stream according to a screenshot interval, detecting whether the feature image exists in the video screenshot, and outputting the video screenshot based on the feature image being detected in the video screenshot.

Abstract: Semiconductor device and fabrication method are provided.

Abstract: Provided in the present application are a recombinant sendai virus vector vaccine expressing immunodominant antigens of mycobacterium tuberculosis, and can be used as therapeutic and preventive antituberculosis vaccine.

Abstract: The present invention provides new methods and kits for treating and preventing bacterial infection.

Abstract: An automatic bulk filling process for filling a large number of liquid containers (20) simultaneously which consists of placing the open-topped liquid containers upside down in a rack (22). The rack is then inserted into a vacuum chamber (28) and positioned directly above a tray (38) that contains a liquid medicinal product (40). The next step is to evacuate the chamber to a predetermined level below atmospheric pressure and then lowering the rack until the containers are partially immersed in the liquid product. Following that step, nitrogen is introduced into the vacuum chamber at a predetermined gradual rate, thereby quickly forcing the medicinal liquid product into the containers. The rack is then raised from the tray containing the liquid medicinal product and removed from the chamber as another rack full of containers is simultaneously inserted into the chamber from the other end.

Abstract: A covering assembly includes a base and a cover slidably mating with the base. The base includes a cavity bounded by a plurality of sidewalls, at least one slide-rail set on the sidewalls, a hole defined in at least one of the sidewalls, for allowing cables to extend therethrough, and a protrusion set on the at least one slide-rail. The cover includes a coping for covering the cavity, at least one fixing portion set on one side of the coping, configured for slidably engaging with the at least one slide-rail, and a gap defined in the at least one fixing portion configured for engaging with the protrusion to prevent the cover withdrawing from the base. A notebook computer incorporating the covering assembly is also disclosed.

Abstract: Novel &agr;-pyrones are described. The &agr;-pyrones are useful in a method for controlling &agr;-pyrone responsive states in a mammal. The method includes administering to a mammal a therapeutically effective amount of an &agr;-pyrone such that control of &agr;-pyrone responsive states in a mammal occurs. &agr;-Pyrone responsive states can be associated with undesirable cell proliferation such as bacteria or cancer. Packaged pharmaceuticals and pharmaceutical compositions including the novel &agr;-pyrones are also described.

Abstract: A method of treating cancer with a pharmaceutical composition containing a pine root (Deutero Mycetes) fungal metabolite or an analog or derivative thereof.

Abstract: Novel &agr;-pyrones are described. The &agr;-pyrones are useful in a method for controlling &agr;-pyrone responsive states in a mammal. The method includes administering to a mammal a therapeutically effective amount of an &agr;-pyrone such that control of &agr;-pyrone responsive states in a mammal occurs. &agr;-Pyrone responsive states can be associated with undesirable cell proliferation such as bacteria or cancer. Packaged pharmaceuticals and pharmaceutical compositions including the novel &agr;-pyrones are also described.

Abstract: A pine root (Deutero mycetes) fungal metabolite and analogs thereof having antifungal activity.

Abstract: Novel .alpha.-pyrones are described. The .alpha.-pyrones are useful in a method for controlling .alpha.-pyrone responsive states in a mammal. The method includes administering to a mammal a therapeutically effective amount of an .alpha.-pyrone such that control of .alpha.-pyrone responsive states in a mammal occurs. .alpha.-Pyrone responsive states can be associated with undesirable cell proliferation such as bacteria or cancer. Packaged pharmaceuticals and pharmaceutical compositions including the novel .alpha.-pyrones are also described.

Abstract: A method of treating cancer with a pharmaceutical composition containing a pine root (Deutero Mycetes) fungal metabolite or an analog or derivative thereof.

Abstract: A pine root (Deutero mycetes) fungal metabolite and analogs thereof having antifungal activity.

Abstract: The invention features two novel antibiotics, termed 15352A and 15352B, having the structures shown in the figures.

Abstract: A natural product of Aspergillus fumigatus and specific derivatives thereof, and a method of treating fungal infection therewith.